Nisa Investment Advisors’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.98M Sell
32,913
-8,153
-20% -$748K 0.01% 509
2025
Q4
$3.7M Buy
41,066
+2,369
+6% +$225K 0.01% 476
2025
Q3
$3.82M Sell
38,697
-25,626
-40% -$2.54M 0.01% 467
2025
Q2
$5.88M Buy
64,323
+1,036
+2% +$100K 0.03% 374
2025
Q1
$7.18M Buy
63,287
+188
+0.3% +$20.1K 0.04% 328
2024
Q4
$6.68M Buy
63,099
+729
+1% +$78.2K 0.03% 378
2024
Q3
$6.75M Sell
62,370
-6,237
-9% -$681K 0.04% 358
2024
Q2
$7.46M Sell
68,607
-1,419
-2% -$167K 0.05% 338
2024
Q1
$9.26M Buy
70,026
+1,083
+2% +$135K 0.06% 282
2023
Q4
$8.39M Sell
68,943
-1,654
-2% -$185K 0.06% 286
2023
Q3
$7.92M Sell
70,597
-415
-0.6% -$52.7K 0.06% 298
2023
Q2
$10.3M Buy
71,012
+200
+0.3% +$27.2K 0.08% 260
2023
Q1
$9.15M Buy
70,812
+352
+0.5% +$44.2K 0.07% 277
2022
Q4
$8.98M Buy
70,460
+23
+0% +$2.67K 0.07% 290
2022
Q3
$7.37M Buy
70,437
+4,858
+7% +$533K 0.06% 295
2022
Q2
$6.89M Sell
65,579
-4,985
-7% -$591K 0.06% 298
2022
Q1
$9.03M Sell
70,564
-7,317
-9% -$882K 0.06% 285
2021
Q4
$9.3M Buy
77,881
+7,677
+11% +$1M 0.07% 275
2021
Q3
$9.98K Sell
70,204
-749
-1% -$110K 0.06% 284
2021
Q2
$11.1K Sell
70,953
-3,466
-5% -$561K 0.07% 258
2021
Q1
$11.6K Sell
74,419
-30
-0% -$4.65K 0.07% 250
2020
Q4
$11.1M Buy
74,449
+4,259
+6% +$602K 0.07% 257
2020
Q3
$9.28M Sell
70,190
-4,256
-6% -$556K 0.07% 246
2020
Q2
$8.63M Sell
74,446
-6,114
-8% -$705K 0.08% 236
2020
Q1
$7.91M Sell
80,560
-3,134
-4% -$411K 0.09% 217
2019
Q4
$12.2M Sell
83,694
-961
-1% -$133K 0.1% 203
2019
Q3
$11.3M Buy
84,655
+1,463
+2% +$189K 0.1% 208
2019
Q2
$9.51M Sell
83,192
-4,913
-6% -$575K 0.09% 223
2019
Q1
$10.9M Buy
88,105
+4,631
+6% +$526K 0.11% 199
2018
Q4
$8.41M Sell
83,474
-433
-0.5% -$48.7K 0.09% 213
2018
Q3
$10.7M Buy
83,907
+11,231
+15% +$1.34M 0.1% 211
2018
Q2
$7.86M Sell
72,676
-319
-0.4% -$34.7K 0.08% 241
2018
Q1
$7.82M Buy
72,995
+1,854
+3% +$215K 0.08% 238
2017
Q4
$8.34M Buy
71,141
+309
+0.4% +$34.9K 0.09% 233
2017
Q3
$8.05M Buy
70,832
+3,038
+4% +$351K 0.09% 221
2017
Q2
$8.39M Sell
67,794
-1,030
-1% -$122K 0.1% 218
2017
Q1
$8.16M Sell
68,824
-5
-0% -$567 0.1% 227
2016
Q4
$6.9M Sell
68,829
-510
-0.7% -$54.7K 0.08% 249
2016
Q3
$8.75M Hold
69,339
0.11% 208
2016
Q2
$8.1M Buy
69,339
+1,937
+3% +$219K 0.11% 209
2016
Q1
$6.98M Sell
67,402
-2,678
-4% -$259K 0.1% 211
2015
Q4
$6.98M Buy
70,080
+566
+0.8% +$55.4K 0.1% 205
2015
Q3
$6.38M Buy
69,514
+309
+0.4% +$31K 0.1% 211
2015
Q2
$7.34M Sell
69,205
-1,960
-3% -$217K 0.1% 200
2015
Q1
$8.12M Buy
71,165
+1,082
+2% +$123K 0.11% 193
2014
Q4
$7.72M Sell
70,083
-1,236
-2% -$130K 0.11% 199
2014
Q3
$6.96M Buy
71,319
+824
+1% +$81K 0.1% 209
2014
Q2
$7.11M Buy
70,495
+1,030
+1% +$100K 0.1% 212
2014
Q1
$6.38M Hold
69,465
0.09% 214
2013
Q4
$6.29M Sell
69,465
-968
-1% -$83.8K 0.09% 216
2013
Q3
$5.62M Sell
70,433
-618
-0.9% -$48.6K 0.09% 223
2013
Q2
$5.17M Buy
+71,051
New +$5.31M 0.08% 229

Other funds holding ZBH

Nisa Investment Advisors's ZBH Position: Q1 2026 in Review

Nisa Investment Advisors reduced its Zimmer Biomet (ZBH) stake by 20% in Q1 2026, selling an estimated $748K and leaving 32,913 shares worth $2.98M. The position accounts for 0.01% of the portfolio, ranked #509.

Nisa Investment Advisors first reported a position in ZBH in Q2 2013 and has held it in 52 quarters since. The position peaked at $12.2M in Q4 2019. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

  • Nisa Investment Advisors held 32,913 shares of Zimmer Biomet worth $2.98M as of Q1 2026.
  • Nisa Investment Advisors sold 8,153 Zimmer Biomet shares in Q1 2026, an estimated $748K.
  • Zimmer Biomet made up 0.01% of Nisa Investment Advisors's portfolio in Q1 2026, its #509 holding.
  • Nisa Investment Advisors first reported a position in Zimmer Biomet in Q2 2013 and has held it in 52 quarters since.
  • Nisa Investment Advisors's Zimmer Biomet position peaked at $12.2M in Q4 2019.
  • 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on Nisa Investment Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.